The U.S. Securities and Exchange Commission's top enforcement chief warned on Tuesday that too many pharmaceutical companies are failing to accurately portray their dealings with federal drug regulators - a problem that could get them in trouble.
Tags: FDA
GNC Alleged of Selling Products Containing Illicit Substances
General Nutrition Corporation or GNC is on the hot seat as it is being accused of selling dietary supplements incorporated with illegal additives. Along with other sellers, GNC received notification letters from the New York Attorney General's office saying that it had been unable to verify several supplements contained in the label or some ingredients are not listed in the label.
Former Merck & Co analyst enters guilty plea for insider trading
A former Merck and Co Inc financial analyst was sentenced to three years and a month in prison for insider trading charge by the US Attorney of New York.
Secret function in Apple Watch surprises enthusiasts; heart rate sensor can do more
A teardown of the Apple Watch discovered that it can not only monitor a wearer’s heart rate, but could also measure a person’s blood oxygen levels.
When it comes to e-cigs, Big Tobacco is concerned for your health
The health warning on a MarkTen electronic cigarette package is 116 words long. That's much longer than the warnings on traditional cigarette packs in the United States.
Latest News
The U.S. Food and Drug Administration said it approved Japan's Eisai Co Ltd's drug to treat the most common form of thyroid cancer more than two months ahead of the review date.
A steep fall in Ebola cases in Liberia will make it hard to prove whether experimental vaccines work in a major clinical trial about to start in the country, the head of the U.S. National Institutes of Health (NIH) said on Saturday.
The U.S. Food and Drug Administration has approved NPS Pharmaceuticals Inc's drug Natpara to treat a rare hormone disorder, validating a bet by Shire Plc, which recently agreed to acquire NPS for $5.2 billion.
Shire Plc has agreed to buy NPS Pharmaceuticals Inc for $5.2 billion in its biggest acquisition yet, as the Dublin-based drugmaker strengthens its position in the lucrative field of medicines for rare diseases.
NeuroDerm Ltd's shares more than doubled in value on Tuesday, after the company said data from a mid-stage study suggested that a higher dose of its Parkinson's drug could provide an alternative to treatments that require surgery.
Roche Holding AG said U.S. health regulators have approved its Ebola test for emergency use in response to the world's worst outbreak of the disease in West Africa
AstraZeneca Plc's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after the treatment was approved by the European Commission.
The U.S. Food and Drug Administration said on Friday it expects China, after almost two years of delays, to soon approve visas that will allow the agency to more than double its staff in China.
Artificial sweetener maker NutraSweet Co said on Wednesday it would exit its aspartame business by the end of the year, citing increasing foreign competition.
